Merck’s Involvement Confirmed for the Barclays 26th Annual Global Healthcare Conference

Merck (NYSE: MRK), also known as MSD outside the United States and Canada, has revealed that Jannie Oosthuizen, President of Human Health U.S., is set to engage in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 3:05 p.m. EDT.

Interested parties, including investors, analysts, media representatives, and the public, are encouraged to tune in to the live audio webcast of the presentation at the provided web link.

Merck, operating under the name MSD internationally, is committed to leveraging cutting-edge science to enhance and save lives worldwide. With a history spanning over 130 years, Merck has been instrumental in developing crucial medicines and vaccines, aiming to establish itself as a premier research-intensive biopharmaceutical company. Their current focus is on pioneering health solutions that advance disease prevention and treatment for both humans and animals. Merck prioritizes diversity and inclusivity within its global workforce and upholds responsible practices to contribute to a safe, sustainable, and healthy future for all communities.

The forward-looking statements contained in this release by Merck & Co., Inc., Rahway, N.J., USA, are subject to significant risks and uncertainties. Factors such as industry conditions, economic fluctuations, regulatory impacts, technological advancements, and litigation may affect the company’s actual results. Merck does not undertake any obligation to update forward-looking statements based on new information or future events. Further details regarding potential risk factors are available in the company’s filings with the Securities and Exchange Commission (SEC).

Source Link:

Newsletter Updates

Enter your email address below and subscribe to our newsletter